文献速递青光眼

社会剥夺与MI-SIGHT远程医疗青光眼检测项目中青光眼筛查阳性风险的关系

Social Deprivation and the Risk of Screening Positive for Glaucoma in the MI-SIGHT Telemedicine-Based Glaucoma Detection Program.
PubMed 文献 · Ophthalmology · 2023-05-19

该横断面研究纳入2020至2022年MI-SIGHT远程医疗青光眼筛查项目的1171名成人参与者,评估贫困与青光眼或疑似青光眼筛查阳性风险的关系。结果显示24%的参与者筛查阳性,筛查阳性与年龄较大、自我认同为黑人或非裔美国人、已有眼科保健医生以及未驾驶私家车赴约(贫困代理指标)相关,且筛查阳性者的区域剥夺指数(ADI)比阴性者更差。个人贫困和社区贫困均与青光眼或疑似青光眼筛查阳性率升高相关。

要点

  • 24%的参与者筛查阳性为青光眼或疑似青光眼。
  • 筛查阳性与年龄较大、黑人或非裔美国人、已有眼科保健医生及未驾驶私家车赴约相关。
  • 筛查阳性者ADI为7.7±2.8,阴性者为7.0±3.2(P=0.002)。

核心结论

  • 以未驾驶私家车赴约评估的个人贫困和社区水平贫困均与青光眼或疑似青光眼筛查阳性率升高相关。

研究设计与样本

  • 2020至2022年开展的横断面研究,纳入1171名年龄≥18岁、无急性眼部症状的成人参与者,来自MI-SIGHT远程医疗青光眼筛查项目,筛查点包括一家免费诊所和一家联邦合格健康中心(FQHC)。

主要发现

  • 1165名(99.5%)参与者完成筛查,其中34%在免费诊所、66%在FQHC。
  • 参与者平均年龄55.1±14.5岁,62%为女性,54%自我报告为黑人或非裔美国人,34%为白人,10%为西班牙裔或拉丁裔,70%年收入低于3万美元。
  • 平均ADI为7.2±3.1;FQHC的ADI高于免费诊所(免费诊所4.5±2.9 vs FQHC 8.5±2.1,P<0.0001)。
  • 24%的参与者筛查阳性为青光眼或疑似青光眼;筛查阳性与年龄较大(P=0.01)、黑人或非裔美国人(P=0.0001)、已有眼科保健医生(P=0.0005)及未驾驶私家车赴约(P=0.001)相关。
  • 筛查阳性者ADI比阴性者更差(7.7±2.8 vs 7.0±3.2,P=0.002);FQHC白人参与者筛查阳性比例高于免费诊所白人参与者(21.3% vs 12.3%,P=0.01),且FQHC白人参与者ADI比免费诊所白人参与者更差(7.5±2.5 vs 3.7±2.7,P<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess whether increased poverty is associated with increased risk of screening positive for glaucoma or suspected glaucoma in a large public screening and intervention program. DESIGN: Cross-sectional study from 2020 to 2022. PARTICIPANTS: Adults ≥ 18 years old without acute ocular symptoms. METHODS: Michigan Screening and Intervention for Glaucoma and eye Health through Telemedicine (MI-SIGHT) program participants' sociodemographic characteristics and area deprivation index (ADI) values were summarized from the clinical sites, which included a free clinic and a Federally Qualified Health Center (FQHC). The ADI, a composite measure of neighborhood deprivation (range, 1-10; 10 is worst deprivation), was assigned on the basis of the participants' addresses. Group comparisons were performed via 2-sample t tests or Wilcoxon Mann-Whitney tests for continuous measures and chi-square tests or Fisher exact tests with Monte Carlo simulation for categorical measures; Holm adjustment was used for multiple comparisons. MAIN OUTCOME MEASURES: Risk factors for screening positive for glaucoma or suspected glaucoma. RESULTS: Of the 1171 enrolled participants, 1165 (99.5%) completed the screening: 34% at the free clinic and 66% at the FQHC. Participants were on average aged 55.1 ± 14.5 years, 62% were women, 54% self-reported as Black/African-American, 34% White, 10% Hispanic or Latino, and 70% earned < $30 000 annually. The mean ADI was 7.2 ± 3.1. The FQHC had higher (worse) ADI than the free clinic (free clinic: 4.5 ± 2.9, FQHC: 8.5 ± 2.1, P < 0.0001). One-quarter (24%) of participants screened positive for glaucoma or suspected glaucoma. Screening positive for glaucoma or suspected glaucoma was associated with being older (P = 0.01), identifying as Black/African-American (P = 0.0001), having an established eyecare clinician (P = 0.0005), and not driving a personal vehicle to the appointment (P = 0.001), which is a proxy for increased poverty. Participants who screened positive had worse ADI than those who screened negative (7.7 ± 2.8 vs. 7.0 ± 3.2, P = 0.002). A larger percentage of White participants screened positive at the FQHC compared with White participants at the free clinic (21.3% vs. 12.3%, P = 0.01). FQHC White participants had worse ADI than free clinic White participants (7.5 ± 2.5 vs. 3.7 ± 2.7, P < 0.0001). CONCLUSIONS: Personal poverty, assessed as not driving a personal vehicle to the appointment, and neighborhood-level poverty were both associated with increased rates of screening positive for glaucoma or suspected glaucoma. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Newman-Casey PA, Aliancy J, Lu MC, et al. Social Deprivation and the Risk of Screening Positive for Glaucoma in the MI-SIGHT Telemedicine-Based Glaucoma Detection Program. Ophthalmology. 2023. PMID: 37211338. doi:10.1016/j.ophtha.2023.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。